Quick Takeaways: Why It Matters? VETARYS and Antigenesis are advancing a potential canine cancer immunotherapy that adapts human oncology approaches for veterinary use. A subcutaneous formulation suitable for primary-care clinics could broaden access beyond specialist cen...
